Publicacións nas que colabora con Angelina Cañizares Castellanos (13)

2022

  1. Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV

    AIDS, Vol. 36, Núm. 5, pp. 691-695

2021

  1. Resistance-associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure

    Journal of Viral Hepatitis, Vol. 28, Núm. 9, pp. 1319-1324

2020

  1. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

    Antiviral Research, Vol. 174

  2. Incidence, risk factors and prognostic impact of cytomegalovirus infection after heart transplantation

    Medicina Clinica, Vol. 154, Núm. 10, pp. 381-387

2019

  1. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain

    Frontiers in Microbiology, Vol. 10, Núm. APR

2016

  1. Any impact of blips and low-level viraemia episodes among HIV-infected patients with sustained virological suppression on ART?

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1051-1055

2015

  1. Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak

    Infection, Genetics and Evolution, Vol. 30, pp. 96-101

  2. Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years

    Journal of Medical Virology, Vol. 87, Núm. 8, pp. 1319-1326

2014

  1. High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response

    AIDS, Vol. 28, Núm. 12, pp. 1837-1840

  2. Seroprevalence of HCV and HIV infections by year of birth in Spain: Impact of US CDC and USPSTF recommendations for HCV and HIV testing

    PLoS ONE, Vol. 9, Núm. 12

2012

  1. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: Effect of preemptive therapy

    Transplantation Proceedings

2002

  1. Prevention of cytomegalovirus disease after heart transplantation: Preemptive therapy with 7 days' intravenous ganciclovir

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 69-70

1999

  1. Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients

    Transplantation Proceedings